Skip to Content

PAN 5 (Pancrelipase Delayed-Release 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease)

Pill with imprint PAN 5 is White, Capsule-shape and has been identified as Pancrelipase Delayed-Release 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease. It is supplied by X-GEN Pharmaceuticals, Inc..

Pancrelipase is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancrelipase 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAN 5

Pancrelipase delayed-release 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease PAN 5

Pancrelipase Delayed-Release

Imprint
PAN 5
Strength
16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease
Color
White
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
X-GEN Pharmaceuticals, Inc.
National Drug Code (NDC)
39822-0205

Get help with Imprint Code FAQs.

Related Images for "PAN 5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.